CHRISTOPHER CARLISLE: Open Payments
NPI 1477559375 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$840 in 23 payments from 8 companies in 2025. Trend: 2023 $602 · 2024 $252 · 2025 $840
Food & beverage: $840
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 9 | $442 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| Arcutis Biotherapeutics, Inc. | 1 | $121 |
| ABIOMED | 1 | $60 |
| Organon LLC | 8 | $31 |
| Incyte Corporation | 1 | $23 |
| Galderma Laboratories, L.P. | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
Products named: OTEZLA, DUPIXENT, Zoryve, OPZELURA, NEMLUVIO, COSENTYX, VTAMA.
Industry payments across FL — which companies pay providers there.
